Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 3; Last updated: 2025-07-01 16:47:40+0000
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/Evidence/379741
identifier: FEvIR Object Identifier/379741
name: Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan
title: Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan
citeAs:
Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379741. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379741. Computable resource at: https://fevir.net/resources/Evidence/379741#json.
status: Active
author: Joanne Dehnbostel:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
Type | Target[x] |
Part Of | Outcome Measure Report for QUARTET USA Trial |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
variableRole: Population
variableDefinition
variableRole: Outcome
observed: Add-on Amlodipine at 6 weeks
statistic
statisticType: odds ratio
quantity: 0.08
numberAffected: 22
SampleSizes
Extension NumberOfParticipants KnownDataCount 62 60 attributeEstimate
type: confidence interval
level: 0.95
range: 0.02-0.41
attributeEstimate
type: p-value
quantity: 0.003